Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,594 | -7,129 | -5,052 | -3,452 | -1,689 |
| Depreciation Amortization | 58 | 195 | 146 | 98 | 49 |
| Accounts receivable | -18 | N/A | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 440 | 152 | -151 | 34 | -96 |
| Other Working Capital | 315 | -637 | -377 | 13 | -104 |
| Other Operating Activity | -443 | -254 | -172 | -253 | 31 |
| Operating Cash Flow | $-2,243 | $-7,674 | $-5,607 | $-3,560 | $-1,808 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -4 | -4 | -1 | -1 |
| Investing Cash Flow | $0 | $-4 | $-4 | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,442 | 4,530 | 0 | 0 | 0 |
| Other Financing Activity | 150 | 1,225 | 1,225 | 100 | 100 |
| Financing Cash Flow | $6,592 | $5,755 | $1,225 | $100 | $100 |
| Beginning Cash Position | 4,721 | 6,644 | 6,644 | 6,644 | 6,644 |
| End Cash Position | 9,071 | 4,721 | 2,258 | 3,183 | 4,934 |
| Net Cash Flow | $4,349 | $-1,923 | $-4,386 | $-3,461 | $-1,710 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,243 | -7,674 | -5,607 | -3,560 | -1,808 |
| Capital Expenditure | 0 | -4 | -4 | -1 | -1 |
| Free Cash Flow | -2,243 | -7,678 | -5,611 | -3,561 | -1,810 |